300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
CleanTech
Retail
Oil and Gas
Film
Marketplace
Payments
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Music
Publishing
Mobile Apps
Wine and Spirits
Art
Manufacturing
FinTech
Finance
Digital Media
Real Estate
Social Media
Financial Services
Sporting Goods
Franchise
Non Profit
Android
Internet
Mobile Advertising
Proptech
Impact
Sustainability
Enterprise
Hardware
Biotech
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Taiwan
Egypt
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Zimbabwe
Tunisia
Sweden
Oceania
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Europe
Qatar
Bangladesh
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Jersey
Bahrain
Ecuador
Estonia
Bolivia
Belize
Bahamas
Algeria
Italy
Belarus
Hungary
Finland
Grenada
Israel
Lithuania
Liechtenstein
Honduras
Iceland
Cambodia
Mongolia
Lebanon
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Springtec Investment Inc

VC Fund

Taipei, Taiwan

Springtec Investment Inc is a VC fund in Taipei focused on Medical and Health Care. Investment

Total investments:
1
Last investment:
Lead investor:
100%

Last updated:

Industries Springtec Investment Inc invests in

MedicalHealth CareBiotechnologyArtificial Intelligence

Stages Springtec Investment Inc invests in

Pre-Seed

Countries Springtec Investment Inc invests in

Taiwan

Investment Focus

Industry

  • Medical 1 (100%)
  • Health Care 1 (100%)
  • Biotechnology 1 (100%)
  • Artificial Intelligence 1 (100%)

Investments

CompanyDescriptionRoundLinks
CancerFree Biotech's platform E.V.A. (Ex Vivo Avatar) uses a proprietary culture system and AI image recognition to expand circulating tumor cells from just 20 mL of blood into 3D tumor organoids. These organoids drive personalized treatment by facilitating drug sensitivity testing and identifying the most effective drugs for each patient. Bytesting therapies directly on patient-derived cells and conducting proprietary organoid analysis, E.V.A. generates personalized screening reports tailored to each patient's unique tumor profile. E.V.A. also supports pharmaceutical companies by validating drug efficacy on patient-derived cells and identifying the most promising candidates for clinical trials. The organoid screening data offers early insights into drug efficacy, reducing the risk of late-stage trial failure and helping to select the best-in-class therapies. Additionally, as a more physiologically relevant model, E.V.A. eliminates the need for traditional cell line and animal testing, producing more accurate and clinically predictive data. $428.6K / Pre-Seed / Apr 15, 2021

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
CleanTech
Retail
Oil and Gas
Film
Marketplace
Payments
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Music
Publishing
Mobile Apps
Wine and Spirits
Art
Manufacturing
FinTech
Finance
Digital Media
Real Estate
Social Media
Financial Services
Sporting Goods
Franchise
Non Profit
Android
Internet
Mobile Advertising
Proptech
Impact
Sustainability
Enterprise
Hardware
Biotech
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Taiwan
Egypt
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Zimbabwe
Tunisia
Sweden
Oceania
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Europe
Qatar
Bangladesh
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Jersey
Bahrain
Ecuador
Estonia
Bolivia
Belize
Bahamas
Algeria
Italy
Belarus
Hungary
Finland
Grenada
Israel
Lithuania
Liechtenstein
Honduras
Iceland
Cambodia
Mongolia
Lebanon
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Springtec Investment Inc invest in?

Springtec Investment Inc invests primarily in Medical, Health Care and Biotechnology startups, most often at Pre-Seed stage. Most of the 1 investments tracked by Shizune back companies in Taiwan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Springtec Investment Inc last invest?

The most recent investment recorded for Springtec Investment Inc closed in Apr 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Springtec Investment Inc Find emails